Directors inflated the price Genzyme shares through false and misleading statements about its new drugs, shareholders claim in Boston Federal Court.
Directors of Airvana are selling the company too cheaply to 72 Mobile Holdings, for $7.65 per share, or $530 million, shareholders claim in Delaware Chancery Court.
Directors of Harleysville National Corp. are selling the company too cheaply to Niagara Financial Group, for $5.50 a share, or $237 million, shareholders claim in Philadelphia Federal Court.
ZiLOG is selling itself too cheaply to IXYS Corp. and Zanzibar Acquisition, for $3.59 a share, or $62.4 million, shareholders claim in Delaware Chancery Court.
Subscribe to Closing Arguments
Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.